Showing results (501-510 of 512) with videos related to

Sort By:
Pageof 52
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 12, 2020
Randomized phase-III-trial of concurrent chemoradiation for locally advanced head and neck cancer comparing dose reduced radiotherapy with paclitaxel/cisplatin to standard radiotherapy with fluorouracil/cisplatin: The PacCis-trialRainer Fietkau, Markus Hecht, Benjamin Hofner, et al.
Cancers|April 30, 2021
Implementation of Double Immune Checkpoint Blockade Increases Response Rate to Induction Chemotherapy in Head and Neck CancerSabine Semrau, Antoniu-Oreste Gostian, Maximilian Traxdorf, et al.
Journal for Immunotherapy of Cancer|October 7, 2020
Safety and efficacy of single cycle induction treatment with cisplatin/docetaxel/ durvalumab/tremelimumab in locally advanced HNSCC: first results of CheckRad-CD8Markus Hecht, Antoniu Oreste Gostian, Markus Eckstein, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 13, 2021
Innovative radiation oncology Together - Precise, Personalized, Human : Vision 2030 for radiotherapy & radiation oncology in GermanyDavid Krug, Markus Hecht, Nadja Ebert, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 23, 2022
Dose-escalated re-irradiation improves outcome in locally recurrent head and neck cancer - Results of a large multicenter analysisJohannes Roesch, Michael Oertel, Simone Wegen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 13, 2025
Benefit of Chemoradiotherapy Versus Chemotherapy After Induction Therapy for Conversion of Unresectable Into Resectable Pancreatic Cancer: The Randomized CONKO-007 TrialRainer Fietkau, Michael Ghadimi, Robert Grützmann, et al.
Pageof 52